The NIH Stimulus — The Recovery Act and Biomedical Research
- 9 April 2009
- journal article
- editorial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 360 (15) , 1479-1481
Abstract
After years of relatively flat funding, the National Institutes of Health (NIH) is poised for rapid growth (see Figure 1 ). In February 2009, under the American Recovery and Reinvestment Act, the NIH received $10.4 billion in new funding. The funds are meant to stimulate the economy as well as to support research and are for expenditure between now and fiscal year 2010, which ends in September of next year.1 In March 2009, Congress finally set the institutes' annual budget for fiscal year 2009 at $30.3 billion, an increase of about 3% from fiscal year 2008. And although details of the Obama administration's fiscal 2010 budget are forthcoming, the spending plan is expected to include more than $6 billion within the NIH as part of a multiyear doubling of funding for cancer research.Keywords
This publication has 3 references indexed in Scilit:
- Health Care and the American Recovery and Reinvestment ActNew England Journal of Medicine, 2009
- Sustaining the Engine of U.S. Biomedical DiscoveryNew England Journal of Medicine, 2007
- The NIH Budget and the Future of Biomedical ResearchNew England Journal of Medicine, 2006